Home/ Supplements/ Feverfew/ Feverfew 455 mg

Feverfew 455 mg

product on market Capsule Solaray Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for Feverfew 455 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 VegCap(s)
Serving Size
100
Servings
Botanical
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

455 mg
Market median: 380.0mg (120 products) 8 studies — no high-quality reviews

Other Ingredients

Cellulose
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Use only as directed. Take one VegCap two times daily with a meal or glass of water.

Warnings & Precautions

Warning: Do not use if safety seal is broken or missing.

Keep out of reach of children.

Keep your licensed health care practitioner informed when using this product.

Do not use if you are pregnant.

Formulation Notes

Tanacetum parthenium 455 mg per capsule Whole leaf

Discussion: Solaray Feverfew leaf is 100% vegan, excipient-free and contain no fillers or additional ingredients.

Discussion: Solaray Feverfew leaf is 100% vegan, excipient-free and contain no fillers or additional ingredients.

Additional Information

Lab Verified

Store in a cool, dry place.

Metadata

Product Details

UPC / SKU0 76280 19276 6
DSLD Entry Date2023-08-23
Product TypeBotanical
FormCapsule
BrandSolaray
DSLD ID296034
Data Updated2026-04-11
Research

Research Evidence

10
Research Sources
48
Avg Quality
4
Systematic Review
4
Rct
1
Meta Analysis
1
Cochrane Review
B Feverfew for preventing migraine.
Cochrane Review The Cochrane database of systematic reviews PubMed
C Feverfew for preventing migraine
Systematic Review The Cochrane database of systematic reviews 2004 PubMed
C Feverfew for preventing migraine
Systematic Review The Cochrane database of systematic reviews 2000 PubMed
C Randomised double-blind placebo-controlled trial of feverfew in migraine prevention
Rct Lancet (London, England) 1988 PubMed
C Feverfew for migraine prophylaxis: a systematic review
Systematic Review Journal of dietary supplements 2009 PubMed DOI
C Tanacetum parthenium and Salix alba (Mig-RL) combination in migraine prophylaxis: a prospective, open-label study
Meta Analysis Clinical drug investigation 2006 PubMed
C The combined effect of acupuncture and Tanacetum parthenium on quality of life in women with headache: randomised study
Rct Acupuncture in medicine : journal of the British Medical Acupuncture Society 2012 PubMed DOI
C A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial
Rct Headache 2004 PubMed
C Feverfew as a preventive treatment for migraine: a systematic review
Systematic Review Cephalalgia : an international journal of headache 1998 PubMed
D Efficacy of feverfew as prophylactic treatment of migraine
Rct British medical journal (Clinical research ed.) 1985 PubMed
View all evidence for Feverfew →
Compare

Similar Products

Migra-None
Douglas Laboratories · Capsule
100
White Willow Feverfew 350 mg
Eclectic Herb · Capsule
100
Feverfew
GNC Herbal Plus Standardized · Capsule
100
Feverfew
Vitabase · Capsule
100
Feverfew Max-V
Douglas Laboratories · Capsule
100
View all Feverfew products →
Feverfew research Best Feverfew All Feverfew products More from Solaray View on NIH DSLD →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.